The Affiliated Mental Health Center of Jiangnan University, Wuxi, China.
Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China.
PLoS One. 2024 Oct 23;19(10):e0311841. doi: 10.1371/journal.pone.0311841. eCollection 2024.
Pharmaceutical health literacy intervention (PHLI) plays a crucial role in influencing patients' medical decision-making, particularly concerning medication use. However, PHLI has not been widely implemented in China. This study aims to develop a novel PHLI model within a psychiatric hospital setting and evaluate its effectiveness.
A PHLI model encompassing four modes-covering inpatients, outpatients, Internet+ and community-was established at The Affiliated Mental Health Center of Jiangnan University. The model's operation was detailed, and its performance data from 2022 and 2023 were evaluated.
In 2022 and 2023, a total of 636 PHLI cases were reported. Of these, 386 cases (60.69%) were identified through the inpatient mode. The proportion of PHLI delivered via inpatient and Internet information subscription modes gradually increased, while interventions through other methods decreased. The age group of 18-30 accounted for 21.97% of cases, with 116 instances reported. Various types of PHLI were provided, including adverse reactions (18.87%), dosage and administration (11.64%), and therapeutic drug monitoring (9.43%). In addition, intervention strategies primarily focused on adverse reaction identification (10.22%), interpretation of pharmaceutical reports (7.23%), and routine examination reminders (6.45%).
The PHLI model developed at our hospital offers an effective approach to health literacy intervention and represents an innovation advancement in pharmaceutical health literacy management. It can also serve as a reference framework for other hospitals.
药品健康素养干预（PHLI）在影响患者医疗决策方面起着至关重要的作用，尤其是在药物使用方面。然而，PHLI 在中国尚未得到广泛实施。本研究旨在开发一种新的 PHLI 模型，并评估其在精神科医院环境中的效果。
在江南大学附属精神卫生中心建立了一种包含住院患者、门诊患者、互联网+和社区四个模式的 PHLI 模型。详细描述了该模型的运作方式，并评估了其 2022 年和 2023 年的表现数据。
2022 年和 2023 年共报告了 636 例 PHLI 案例。其中，386 例（60.69%）通过住院模式识别。通过住院和互联网信息订阅模式提供 PHLI 的比例逐渐增加，而通过其他方法进行干预的比例则有所下降。年龄在 18-30 岁的患者占 21.97%，有 116 例报告。提供了各种类型的 PHLI，包括不良反应（18.87%）、剂量和给药途径（11.64%）和治疗药物监测（9.43%）。此外，干预策略主要集中在识别不良反应（10.22%）、解释药品报告（7.23%）和常规检查提醒（6.45%）。
本研究开发的 PHLI 模型为健康素养干预提供了一种有效方法，是药品健康素养管理方面的创新进步，也可为其他医院提供参考框架。
